124 related articles for article (PubMed ID: 25866319)
21. Epidemiological and clinical features of moyamoya disease in the USA.
Kainth D; Chaudhry SA; Kainth H; Suri FK; Qureshi AI
Neuroepidemiology; 2013; 40(4):282-7. PubMed ID: 23445954
[TBL] [Abstract][Full Text] [Related]
22. Moyamoya disease in a Moroccan baby: a case report.
Houba A; Laaribi N; Meziane M; Jaafari A; Abouelalaa K; Bensghir M
J Med Case Rep; 2018 Jun; 12(1):165. PubMed ID: 29895322
[TBL] [Abstract][Full Text] [Related]
23. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
Hayashi T; Shirane R; Fujimura M; Tominaga T
J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
[TBL] [Abstract][Full Text] [Related]
24. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
King JA; Armstrong D; Vachhrajani S; Dirks PB
J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
[TBL] [Abstract][Full Text] [Related]
25. Clinical features, surgical treatment, and long-term outcome in pediatric patients with moyamoya disease in China.
Bao XY; Duan L; Yang WZ; Li DS; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2015; 39(2):75-81. PubMed ID: 25573764
[TBL] [Abstract][Full Text] [Related]
26. Moyamoya disease associated with asymptomatic mosaic Turner syndrome: a rare cause of hemorrhagic stroke.
Manjila S; Miller BR; Rao-Frisch A; Otvos B; Mitchell A; Bambakidis NC; De Georgia MA
J Stroke Cerebrovasc Dis; 2014; 23(5):1242-4. PubMed ID: 24103673
[TBL] [Abstract][Full Text] [Related]
27. Moyamoya Angiopathy: An Underdiagnosed Cause of Ischemic Stroke in a Tunisian Pediatric Cohort.
Bouchaala W; Laroussi S; Mzid Y; Maaloul I; Jallouli O; Zouari S; Ben Nsir S; Mnif Z; Kammoun F; Triki C
Pediatr Neurol; 2024 Jan; 150():3-9. PubMed ID: 37925769
[TBL] [Abstract][Full Text] [Related]
28. Intellectual ability and executive function in pediatric moyamoya vasculopathy.
Williams TS; Westmacott R; Dlamini N; Granite L; Dirks P; Askalan R; Macgregor D; Moharir M; Deveber G
Dev Med Child Neurol; 2012 Jan; 54(1):30-7. PubMed ID: 22117564
[TBL] [Abstract][Full Text] [Related]
29. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.
Khan N; Schuknecht B; Boltshauser E; Capone A; Buck A; Imhof HG; Yonekawa Y
Acta Neurochir (Wien); 2003 Dec; 145(12):1061-71; discussion 1071. PubMed ID: 14663563
[TBL] [Abstract][Full Text] [Related]
30. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
[TBL] [Abstract][Full Text] [Related]
31. Disparities in the symptomatic presentation of Moyamoya disease in the United States: A nationwide all-payer analysis.
Fuentes AM; Chiu RG; Mehta AI
J Clin Neurosci; 2021 May; 87():92-96. PubMed ID: 33863543
[TBL] [Abstract][Full Text] [Related]
32. Focal time-to-peak changes on perfusion MRI in children with Moyamoya disease: correlation with conventional angiography.
Choi HS; Kim DS; Shim KW; Kim J; Kim ES; Lee SK
Acta Radiol; 2011 Jul; 52(6):675-9. PubMed ID: 21525108
[TBL] [Abstract][Full Text] [Related]
33. Moyamoya disorder in the United States.
Starke RM; Crowley RW; Maltenfort M; Jabbour PM; Gonzalez LF; Tjoumakaris SI; Randazzo CG; Rosenwasser RH; Dumont AS
Neurosurgery; 2012 Jul; 71(1):93-9. PubMed ID: 22418580
[TBL] [Abstract][Full Text] [Related]
34. How commonly do children with complex cerebral arteriopathy have renovascular disease?
Willsher A; Roebuck DJ; Ng J; Ganesan V
Dev Med Child Neurol; 2013 Apr; 55(4):335-40. PubMed ID: 23253043
[TBL] [Abstract][Full Text] [Related]
35. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events.
Dobson SR; Holden KR; Nietert PJ; Cure JK; Laver JH; Disco D; Abboud MR
Blood; 2002 May; 99(9):3144-50. PubMed ID: 11964276
[TBL] [Abstract][Full Text] [Related]
36. Moyamoya syndrome in a child with down syndrome.
Bhalala US; Parekh PR
Indian J Pediatr; 2005 Jul; 72(7):635-7. PubMed ID: 16077250
[TBL] [Abstract][Full Text] [Related]
37. Clinical Presentation and Stroke Incidence Differ by Moyamoya Etiology.
Gatti JR; Torriente AG; Sun LR
J Child Neurol; 2021 Mar; 36(4):272-280. PubMed ID: 33155871
[TBL] [Abstract][Full Text] [Related]
38. Quality of Life in Pediatric Moyamoya Disease.
Ball AJ; Steinberg GK; Elbers J
Pediatr Neurol; 2016 Oct; 63():60-65. PubMed ID: 27473648
[TBL] [Abstract][Full Text] [Related]
39. Presumed perinatal stroke in a child with Down syndrome and moyamoya disease.
Pysden K; Fallon P; Moorthy B; Ganesan V
Dev Med Child Neurol; 2010 Feb; 52(2):212-4. PubMed ID: 19583743
[TBL] [Abstract][Full Text] [Related]
40. The disease presentation of Moyamoya angiopathy in Eastern India.
Das S; Dubey S; Acharya M; Ghosh R; Chatterjee S; Hazra A; Lahiri D; Segupta S; Chatterjee S; Das G; Sarkar N; Ray BK; Kraemer M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104957. PubMed ID: 32689603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
